BeStock  
Stocks › Biotechnology › KURA

Kura Oncology KURA

US equityMarket cap rank #3454Biotechnology
$6.91 −$0.44 (-5.99%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.94 +0.43%
Open$7.13
Prev close$7.35
Day range$6.89 – $7.37
Volume1.75M
Market cap$634.88M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-2.4x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -5.7x

Price / book39.8x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 3.7x

#5231 of 5329 stocks by PB (1 = cheapest)

Price / sales9.0x
CheapRich

Near the top of its 5-year range · 80th percentile, 5-year average 3.5x

#4432 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-12x-8x-5x-1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$11.51
Price vs. fair value-40.0%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 39.85 – 3.69 100% (pricier than usual) #5231 of 5329 (1 = cheapest)
PE -2.35 -2.81 -5.73 99% (pricier than usual) –
PS 9.00 4.46 3.46 80% (pricier than usual) #4432 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on KURA.

Sign in to join the discussion.

Scroll to Top